You are here

News

Tuesday, November 5, 2019
Link to Event page
Wednesday, October 30, 2019
DURHAM – When a person gets sick, the invading virus or bacteria often triggers an immune response, sending a wave of white blood cells to attack the source of the illness. While the body’s natural defenses can often dismantle the infection, the immune reaction can sometimes cause more harm than...
Wednesday, October 30, 2019
Please see Event page for details.
Friday, October 25, 2019
A team of Gladstone scientists and their partners at Xyphos Biosciences, Inc. describe a new way of attacking cells infected by HIV in this week's issue of the journal Cell. The work showcases a novel version of CAR-T, the technology known for its recent successes in fighting blood cancers. With...
Thursday, October 24, 2019
Please see the new NIAID Funding Opportunity: PAR-20-036, Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States
Friday, October 4, 2019
Please see this flyer for scholarship information for the upcoming HIV Vaccines Conference at Keystone, March 22-26, 2020.
Not only are KS Scholarships prestigious, but they also provide up-and-coming scientists with invaluable networking and career-development opportunities to advance their...
Friday, October 4, 2019
Please see this flyer for the Emory CFAR’s 2nd Annual Planning for Success course. This intensive NIH R-level grant writing course is open to all eligible CFAR faculty. 
“Planning for Success” (PfS) is for CFAR faculty who:
Are interested in building a career as an NIH-funded independent...
Friday, September 20, 2019
Registration is now open for Part II (Design, analysis and interpretation of experiments) of the 3-part series of workshops designed to provide HIV researchers with the quantitative skills necessary for analysis of the large, complex data sets resulting from assays such as single-cell RNA-seq, flow...
Thursday, September 5, 2019
American Society for Microbiology
Washington, DC - September 3, 2019 - Researchers have developed an animal model to test HIV infection and therapies in infants, allowing them to develop biomarkers to predict viral rebound after antiretroviral therapy (ART) interruption. The simian-human...
Thursday, September 5, 2019
Community-Based Research Sets Stage for Implementation of HHS Initiative
September 5, 2019
The National Institutes of Health has awarded approximately $11.3 million to 23 institutions across the United States to collaborate with community partners to develop locally relevant plans for diagnosing,...

Pages